Vice Provost and Dean of Research
Showing 41-50 of 150 Results
-
Robert Hawkins
Assistant Professor of Linguistics and, by courtesy, of Psychology
BioI direct the Social Interaction & Language (SoIL) Lab at Stanford University. We're interested in the cognitive mechanisms that allow people to flexibly communicate, collaborate, and coordinate with one another. We work on these problems using large-scale, multi-player web experiments and computational models of language and social reasoning.
-
Melanie Hayden Gephart
Professor of Neurosurgery and, by courtesy, of Neurology and Neurological Sciences
BioI am a brain tumor neurosurgeon, treating patients with malignant and benign tumors, including gliomas, brain metastases, meningiomas, and schwannomas. I direct the Stanford Brain Tumor Center and the Stanford Brain Metastasis Consortium, collaborative unions of physicians and scientists looking to improve our understanding and treatment of brain tumors. My laboratory seeks greater understanding of the mechanisms driving tumorigenesis and disease progression in malignant brain tumors. We study how rare cancer cell populations survive and migrate in the brain, inadvertently supported by native brain cells. We develop novel cerebrospinal fluid-based biomarkers to track brain cancer treatment response, relapse, and neurotoxicity. Our bedside-to-bench-to-bedside research model builds on a foundation of generously donated patient samples, where we test mechanisms of brain cancer growth, develop novel pre-clinical models that reliably recapitulate the human disease, and facilitate clinical trials of new treatments for patients with brain cancer.
www.GephartLab.com
https://stan.md/BrainMets
@HaydenGephartMD -
Christopher Haynes
Director of Industry and Technology Transactions, Office of Technology Licensing (OTL)
BioChristopher Haynes is the Director of Industry and Technology Transactions within the Industrial Contracts Office, Office of Technology Licensing. In this capacity, Chris is responsible for the oversight of daily activities of the Industrial Contracts Office. Chris has extensive experience drafting and negotiating complex agreements and interfacing with research staff to ensure research objectives are met. Prior to joining Stanford, Chris's career has spanned both pharmaceutical and academic settings. His career experience includes previously roles as Senior Counsel - Licensing and Transactions at Sangamo Therapeutics, Inc., In-House Counsel - Worldwide Research and Discovery (WWRD) and Business Development (BD) at BioMarin Pharmaceutical, Inc., and Commercialization Manager and IP Counsel at the University of Louisville's Office of Technology Transfer.
-
Zihuai He
Associate Professor (Research) of Neurology and Neurological Sciences (Neurology Research), of Medicine (BMIR) and, by courtesy, of Biomedical Data Science
Current Research and Scholarly InterestsStatistical genetics and other omics to study Alzheimer's disease and aging.
-
Sam Heft-Neal
Senior Research Scholar
BioSam Heft-Neal is a Senior Research Scholar at the Center on Food Security and the Environment. Sam is working to identify the impacts of environmental changes on health, agriculture, and food availability around the world. His recent work combines household surveys with remote sensing data to examine environmental drivers of child health. Sam holds a Ph.D. in Agricultural and Resource Economics from the University of California, Berkeley and a B.A. in Statistics and Economics from the same institution.
-
John P. Hegarty II
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioI am a neuroscientist and Principal Investigator of the Stanford Clinical Neuroscience (CNS) Lab in the Department of Psychiatry and Behavioral Sciences as well as Director of Neuroimaging for the Autism and Developmental Disorders Research Program at Stanford. My innovative research studies clinical aspects of cognitive and behavioral neuroscience, with a special focus on examining the neural circuitry associated with important brain-behavior relationships that may underlie different psychological and psychiatric domains in autistic children, adolescents, and adults. The ultimate goal of this research is to improve our understanding of the development of different cognitive and behavioral skills in order to develop mechanistically driven interventions that will improve precision medicine for mental health. Biologically based diagnosis and treatment are extremely limited for most psychological and psychiatric conditions but also critically needed to increase early identification and improve treatment outcomes, especially for neurodevelopmental disorders in which early intervention is the most beneficial. My early career research has primarily focused on clinical neuroscience using neuroimaging (e.g., MRI & EEG) to examine the effects of different drugs and behavioral interventions on the brain, especially for developing biomarkers for improving treatment planning and monitoring biological changes in response to single dose and clinical trials.
My primary contributions to science thus far fall within these major categories: 1) identifying the neural correlates of individual differences in cognition and behavior, 2) developing new interventions and investigating the neurobiological substrates of response to treatment, 3) examining different factors that contribute to brain development, 4) summarizing and increasing accessibility to autism-related research, and 5) methods development for neuroimaging studies. My earliest research investigated the neurobiology of alexithymia, dyslexia, and stress using structural and functional magnetic resonance imaging to test theories of the mechanisms that contribute to differences in cognition and behavior. My subsequent dissertation research, in which I began to focus on neurodevelopmental disorders, examined the neural correlates of response to beta-blockers in autistic adults and also assessed the contribution of cerebellar circuits to the autism phenotype. During my postdoctoral training, I have developed further skills for working with children in multiple clinical research settings, especially for using advanced neuroimaging approaches to examine important brain-behavior relationships. This includes a recent K99/R00 from the National Institute of Child Health and Human Development (NCT04278898 & NCT05664789) that will assess the neurobiology of restricted and repetitive behaviors in autistic children and examine the efficacy and target engagement of a novel nutritional supplement and investigational drug, N-acetylcysteine (NAC), in the brain. You can find more information about our NAC studies at https://redcap.link/NACandAutism.
